| Janet Zornes, | |
|
2600 N Broadway St, Pittsburg, KS 66762-2623 | |
| (620) 232-3066 | |
| Not Available |
| Full Name | Janet Zornes |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2600 N Broadway St, Pittsburg, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043836737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 1-11949 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janet Zornes, 511 S 4th St, Arma, KS 66712-9403 Ph: (620) 235-3835 | Janet Zornes, 2600 N Broadway St, Pittsburg, KS 66762-2623 Ph: (620) 232-3066 |
News Archive
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Scientists and engineers are eager to understand the secret behind bone's lightweight toughness so they can mimic it in the design of new materials, but previous studies have revealed a number of different strength mechanisms at different scales of focus, rather than a single theory.
Female gender increases the risk of stroke in patients with atrial fibrillation (AF) aged >75 years by 20%, according to a study presented today at the ESC Congress 2012. The findings were presented by Anders Mikkelsen, from Denmark.
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
ViroPharma Incorporated today announced that it has entered into an exclusive option to acquire Meritage Pharma, Inc., a private company based in San Diego, CA focused on developing oral budesonide suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus.
› Verified 4 days ago
Mrs. Penny Lynn Vogts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 Fax: 620-231-5881 | |
Mr. Rick M Baker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1102 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-232-0144 Fax: 620-235-3590 | |
Mrs. Megan Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 S Mount Carmel Pl, Pittsburg, KS 66762 Phone: 620-240-8035 Fax: 620-240-8034 | |
Ms. Laura E Sullivan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3303 Grand Oaks Ct, Pittsburg, KS 66762 Phone: 620-231-0843 | |
Douglas Nance, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 | |
Robyn Harrell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Broadway St, Pittsburg, KS 66762 Phone: 620-232-3066 Fax: 620-231-5881 |